Treadmill testing 'reliable indicator of heart risk in older women'

11 December 2012

Treadmill testing can reliably predict the risk of coronary artery disease in women over the age of 65, it has been found.

Research published in the American Journal of Cardiology also found that two specific electrocardiogram (EKG) indicators of heart stress during an exercise treadmill test (ETT) could make its predictions more accurate.

The authors of the study, published in The American Journal of Cardiology, said their results could help make the ETT a more useful clinical test.

In the study, 111 women who had visited their doctors due to chest pain and whose ETT results were positive, indicating they needed further cardiovascular testing, took part in the study.

While just half of the women with positive treadmill tests had coronary artery disease, when the age was pushed up, the predictive value of the ETT rose.

The test successfully predicted arterial disease in just 36 per cent of women in the youngest group (aged 35 to 50 years), but in the 65 and over group identified the condition in 68 per cent.

Posted by Edward Bartel


Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.

Find a treatment, test or scan available at:

or

Find a consultant

Use one or more of the options below to search for a consultant and link through to view their Spire profile.

or

Let us help you

fill out this form and we will get back to you:

Please select a hospital

We can call you

Please enter your details below and we will call you back.

What is the aim of your enquiry?

Please select a hospital

If we are unable to reach you by phone, please include your email address so that we can get in touch...

Categories

Cardiac

© Spire Healthcare Group plc (2016)